Hello,
We have recently purchased a 64-channel BioSemi system. We have 8 'hangdowns' (to record EOG) as well. Can you give me some information on how these 8 sensors work?
Specifically, if I apply two on the mastoids, two under the eyes, two on the temples and two on the nose- does it matter which ...
Search found 5 matches
- Fri Sep 12, 2008 2:14 pm
- Forum: BioSemi Hardware
- Topic: EOG hangdowns
- Replies: 1
- Views: 7991
- Tue Sep 02, 2008 12:53 pm
- Forum: BioSemi Hardware
- Topic: Speed-mode setting on BioSemi AD box
- Replies: 4
- Views: 13381
- Mon Sep 01, 2008 12:43 pm
- Forum: BioSemi Hardware
- Topic: Speed-mode setting on BioSemi AD box
- Replies: 4
- Views: 13381
- Mon Sep 01, 2008 10:53 am
- Forum: BioSemi Hardware
- Topic: Speed-mode setting on BioSemi AD box
- Replies: 4
- Views: 13381
Speed-mode setting on BioSemi AD box
Hello,
We have just purchased a 64-channel BioSemi system. I am unsure as to which speed-mode setting I should be using. I will be recording from 64 electrodes plus 8 flat-type active electrodes (for EOG). Can anyone tell me what the most suitable speed-mode setting would be for this set-up?
From ...
We have just purchased a 64-channel BioSemi system. I am unsure as to which speed-mode setting I should be using. I will be recording from 64 electrodes plus 8 flat-type active electrodes (for EOG). Can anyone tell me what the most suitable speed-mode setting would be for this set-up?
From ...
- Fri Nov 11, 2005 3:28 pm
- Forum: EEG data analysis
- Topic: Female participants
- Replies: 0
- Views: 9950
Female participants
Hello,
we are using a standard 64-channel ERP system with Biosemi sortware. We have so far tested 15 participants. However, although everything appears fine during recording of all participants, upon data analysis (using BESA software), zero percent of trials from FEMALE participants are being ...
we are using a standard 64-channel ERP system with Biosemi sortware. We have so far tested 15 participants. However, although everything appears fine during recording of all participants, upon data analysis (using BESA software), zero percent of trials from FEMALE participants are being ...